#United States #New York #Rosen Law Firm #stock investigation #Viatris Inc

Rosen Law Firm Investigates Viatris Inc.

The Rosen Law Firm, renowned for its advocacy of investor rights, has declared an ongoing examination into possible securities claims on behalf of shareholders of Viatris Inc. (NASDAQ: VTRS). This investigation comes in light of concerns raised about Viatris potentially disseminating materially misleading business information to its investors, which may have significant implications for shareholders seeking compensation.

Background on the Investigation

On February 27, 2025, Viatris disclosed its fourth quarter and full year earnings for 2024, but this announcement was overshadowed by unsettling revelations regarding the company’s operations. Specifically, it was disclosed that after an inspection by the U.S. Food and Drug Administration (FDA) in June 2024 at the company's manufacturing facility in Indore, India, Viatris received a warning letter and import alert from the FDA in December 2024. This alert affected 11 products the company actively distributes, including crucial medications like lenalidomide and everolimus.

The impact of these regulatory setbacks is projected to be substantial, with Viatris estimating a $500 million decrease in total revenues for 2025 and a reduction of approximately $385 million in adjusted EBITDA. When this information was made public, the company's stock faced a steep decline, plummeting by 15.2% in a single day.

Seeking Justice for Investors

In response to these developments, Rosen Law Firm is taking steps to prepare a class action lawsuit aimed at recovering losses incurred by investors due to these unfavorable circumstances. Shareholders who purchased Viatris securities may be entitled to compensation through a contingency fee arrangement, meaning they won't have to cover any upfront costs or legal fees themselves.

For investors interested in joining the prospective class action, they can easily inquire about their eligibility by visiting the law firm’s dedicated webpage or by reaching out directly to attorney Phillip Kim via phone or email. The firm has established a reputation for handling securities class actions, and aims to ensure that affected shareholders receive the justice they deserve.

Why Choose Rosen Law Firm?

Rosen Law Firm distinguishes itself by representing investors worldwide, with a primary focus on securities class actions and shareholder derivative litigation. The firm boasts a remarkable track record and has consistently ranked highly among legal firms dedicated to investor rights. Notably, in 2017, Rosen Law Firm achieved the largest securities class action settlement against a Chinese company at that time and has secured hundreds of millions of dollars for investors over the years.

In 2019 alone, the firm managed to recover over $438 million for its clients. With founder Laurence Rosen recognized as a prominent figure in the plaintiffs' bar, several attorneys within the firm have earned accolades from prestigious legal publications.

Conclusion

For Viatris investors, the ongoing investigation by Rosen Law Firm represents a critical opportunity to address the potential financial harm caused by the company’s alleged misrepresentations. As the situation unfolds, affected shareholders are encouraged to exercise their rights and explore their options for recovery. For continuous updates, individuals are invited to follow Rosen Law Firm on LinkedIn, Twitter, and Facebook.

For inquiries, you can contact the firm directly:

• - Phone: (866) 767-3653
• - Email: [email protected]

Ensure your investment rights are protected – don’t hesitate to reach out for assistance.